RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood and tissue samples from patients with larynx cancer, pharynx cancer, or oral cavity cancer.
OBJECTIVES: Primary * Characterize, morphologically and molecularly, squamous cell carcinoma of the larynx, pharynx, or oral cavity in patients without high-risk factors, such as alcohol consumption, smoking, or occupation. Secondary * Study the impact parameters of morphology, molecular characteristics, and genomics on disease-free survival and overall survival of these patients. * Study the impact parameters of morphological, molecular, and genomic control in the tumor. * Assess, in advanced tumors, the risk of heterogeneity of morphological, molecular, and genomic control in the tumor. OUTLINE: This is a multicenter study. Blood, tumor tissue, and healthy tissue samples are collected before treatment begins. Patients are followed up every 3 months for 2 years (additional biopsies may be collected).
Study Type
OBSERVATIONAL
Enrollment
30
CHU d'Amiens
Amiens, France
CHU de Caen
Caen, France
Centre François Baclesse
Caen, France
Centre Oscar Lambret
Lille, France
Tumor response rate by RECIST criteria
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHRU de Lille
Lille, France
Hôpital de la Timone
Marseille, France
Centre Antoine Lacassagne
Nice, France
CHU de Nîmes
Nîmes, France
CHU de Rouen
Rouen, France